Oruka Therapeutics, Inc. (ORKA) Revenue History
Annual and quarterly revenue from 2012 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ORKA Revenue Growth
ORKA Revenue Analysis (2012–2024)
As of May 8, 2026, Oruka Therapeutics, Inc. (ORKA) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, ORKA's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including REGN (+5.9% YoY), ARQT (+95.3% YoY), and DAWN (+20.6% YoY). Compare ORKA vs REGN →
ORKA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ORKACurrent | $0 | - | - | - | |
 REGN | $14.3B | +5.9% | +11.0% | 24.9% | |
 ARQT | $376M | +95.3% | - | -3.3% | |
 DAWN | $158M | +20.6% | - | -80.8% |
ORKA Historical Revenue Data (2012–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-27,000 | - | $-88,123,000 | - |
| 2022 | $0 | - | $-114,000 | - | $-9,841,000 | - |
| 2021 | $0 | - | $-91,000 | - | $-19,335,000 | - |
| 2020 | $0 | - | $-93,000 | - | $-9,766,000 | - |
| 2019 | $0 | - | $-89,000 | - | $-5,814,000 | - |
| 2018 | $0 | - | $-22,000 | - | $-8,118,000 | - |
| 2017 | $0 | - | $-27,000 | - | $-18,712,000 | - |
| 2016 | $0 | - | $-24,000 | - | $-16,613,000 | - |
| 2015 | $0 | - | $-19,000 | - | $-11,455,000 | - |
| 2014 | $0 | - | $-12,000 | - | $-9,693,000 | - |
See ORKA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ORKA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ORKA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonORKA — Frequently Asked Questions
Quick answers to the most common questions about buying ORKA stock.
Is ORKA's revenue growth accelerating or slowing?
ORKA TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ORKA's long-term revenue growth rate?
Oruka Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ORKA's revenue distributed by segment?
ORKA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2012-2024 are available for download. Segment mix reveals concentration and diversification trends.